| ORIGINAL ARTICLE |
|
|
Department of Chemistry, Faculty of Pharmacy, British University in Egypt, El-Sherouk city, Cairo, Egypt
Corresponding Author: Moataz S. Hendy, Department of Chemistry, Faculty of Pharmacy, British University in Egypt, El-Sherouk city, Cairo 11837, Egypt. Tel: +201006975060; Fax: +20226300010; E-mail: moataz.sobhy@bue.edu.eg.
| |
ABSTRACT |
|
INTRODUCTION |
|
|
EXPERIMENTAL |
|
|
RESULTS AND DISCUSSION OF THE VALIDATION PARAMETERS |
|
|
CONCLUSION |
|
|
REFERENCES |
 |
ABSTRACT
 |
|---|
New UPLC method was developed for determination of sitagliptin and metformin using Symmetry C18 column (100 mm × 2.1 mm, 2.2 μm) and isocratic elution (methanol 20%), pH (3.5) as a mobile phase. The ultraviolet detector was operated at 220 nm and the column temperature was 50°C. Linearity parameters were acceptable over the concentration ranges of 2-12 μgml-1 and 5-35 μgml-1 for sitagliptin and metformin, respectively. The variables were premeditated to adjust the chromatographic conditions using design of experiment. The proposed method was proved to be accurate for the quality control of the mentioned drugs in their pharmaceutical dosage form.
KEY WORDS: Sitagliptin; Metformin; UPLC; Column temperature; factorial design|
|
INTRODUCTION |
|---|
Sitagliptin (SGN), 1,2,4- triazolo [4,3-a] pyrazine,7- [(3R)-3-amino-1-oxo-4- (2,4,5-trifluorophenyl) butyl] -5,6,7,8- tetrahydro-3- (trifluoromethyl) phosphate (Figure 1a) and metformin hydrochloride (MET), N,N-dimethylimidodicarbonimidic diamide (Figure 1b) are oral hypoglycemic drugs. Some well established liquid chromatographic methods with ultraviolet detection were described for simultaneous determination of SGN and MET in tablets (1-5) and also some spectrophotometric methods were reported (6-8). The aim of the work is to develop a new UPLC method with many advantages over the routine HPLC methods found in the literature (1-5); using simple mobile phase as methanol 20% without ion pairing reagent or buffer, decreased cost as UPLC is more economic than HPLC consuming less organic solvent and less time.
|
|
|
EXPERIMENTAL |
|---|
Instrumentation
The liquid chromatography consisted of a Thermo Fisher UPLC Model Ultimate 3000 (USA), a Symmetry® C18 column (100 mm × 2.1 mm, 2.2 μm) equipped with a Diode Array detector (DAD-3000RS, USA) and an auto sampler (WPS-3000TRS, USA).
Reagents, reference samples and working solutions
Pharmaceutical grade sitagliptin phosphate monohydrate and metformin hydrochloride certified to contain 99.7 % and 99.8 % respectively, Janumet® tablets nominally containing 64.25 mg of sitagliptin phosphate monohydrate and 500 mg of metformin hydrochloride per tablet were kindly supplied from Merck Sharp and Dohme Co. (Egypt). HPLC grade methanol was purchased from Fisher Scientific (UK). Working solutions of SGN (20 µg mL-1) and MET (50 µg mL-1) were prepared separately in the mobile phase.
Sample preparation
Ten tablets of Janumet® were weighed and powdered. An accuratelyweighed amount equivalent to 4 mg of SGN and 31 mg of MET were made up to100 mL with methanol and sonicated to dissolve. The solutions were filtered followed by serial dilutions using the mobile phase to be (4 µg/ml SGN) and (31 µg/ml MET).
Adjustment of chromatographic conditions using factorial design
Optimization of the chromatographic conditions was performed by design of experiment using Minitab® program. In the first step of the factorial design, experimental design was used to detect variables which have imperative influence on the chromatographic performance (Table 1). Two levels were used. A graphical display of each factor was given in a Pareto chart. A factor was considered as “statistically significant” if its effect exceeded a line in the Pareto chart (Figure 2). In the second step of the factorial design, response surface methodology was used where the effect of two variables can be represented as a surface in three-dimensional space and the influence of two variables on the response can be clearly seen in the investigated region (Figure 2).
According to Figure 2, pH was found optimum at 3.5, Column temperature was found optimum at its higher level (50°C) and finally methanol ratio in the mobile phase was found to be at its minimum level. Several columns had been used in the literature for determination of gliptins and metformin. Cyano column was used with good results for some gliptins (9-10) but C18 column also was used successfully for their determination (11). According to the literature, C18 column was used usually for the simultaneous determination of MET in mixtures with gliptins (12), glitazones (13) and gliflozins (14) so C18 column was selected for the enhancement described in this method. pH of the mobile phase (methanol 20%) was adjusted to 3.5 using acetic acid. UV detection at 220 nm was selected. Adjusting column temperature to 50°C enhanced the resolution of peaks. The flow rate was selected to be 0.4 mL min-1 and the injection volume was 10 micro liters. Good resolution between peaks was obtained (Figure 3).
Procedure
Linearity. Aliquots of working solutions equivalent to 20-120 µg and 50-350 µg for SGN and MET, respectively were transferred separately into a series of 10 mL volumetric flasks, completed to volume with the mobile phase and only ten micro liters was injected. A calibration curve was obtained by plotting area under the peak of the corresponding drug against its concentration.
Assay of SGN and MET in lab prepared mixtures (accuracy) and Janumet® tablets. Different ratios of SGN and MET were prepared (SGN: MET, 5:10 µg/mL, 5:5 µg/mL and 10:5 µg/mL). For the determination of SGN and MET in Janumet® tablets, the sample solution was prepared as under 2.3. Only ten micro liters was injected and the concentrations of SGN and MET in lab prepared mixtures and tablets were calculated using their calibration equations.
|
|
|
|
|
RESULTS AND DISCUSSION OF THE VALIDATION PARAMETERS |
|---|
System suitability tests
System suitability tests including number of theoretical plates, tailing factor and resolution between peaks were calculated for the proposed method. The results of these tests are listed in Table 2.
Linearity
A linear relationship between area under the peak and the concentration of each drug was obtained, regression parameters were computed and the linearity of the calibration curves were validated by low values of limit of detection (LOD) and limit of quantification (LOQ) as listed in (Table 3).
Accuracy
Accuracy of the results was confirmed by the recovery percent of each drug in laboratory prepared mixture. The results including the mean of the recovery and standard deviation are shown in (Table 3).
Precision
The three lab prepared mixtures (SGN: MET, 5:10 µg/mL, 5:5 µg/mL and 10:5 µg/mL) were analyzed three times, within the same day and also on three successive days. The %RSD was calculated and found to be less than 2 % in the three concentrations, as shown in (Table 3).
Robustness
The flow rate of the mobile phase was changed from 0.40 mL min-1 to 0.41 mL min-1 and 0.39 mL min-1. The organic strength was changed by % ± 1. And the pH value of the buffer was varied from 3.5 to 3.4 and 3.6. There is no significant difference in the results indicating good robustness of the method.
|
|
|
|
CONCLUSION |
|---|
The proposed method proved to be simple and reproducible for determination of SGN and MET. The method was validated showing good results for all the parameters tested. The developed method can be conveniently used by quality control laboratories.
|
|
REFERENCES |
|---|
